Approval · Notice of Compliance 22563 · 2019
VITRECTO: Notice of Compliance 22563
Issued August 23, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22563
- Date
- August 23, 2019
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- MOXIDECTIN 5.6 MG per 0.4ML
- FLURALANER 112.5 MG per 0.4ML
- MOXIDECTIN 250 MG per 0.89ML
- FLURALANER 12.5 MG per 0.89ML
- MOXIDECTIN 500 MG per 1.79ML
- FLURALANER 25 MG per 1.79ML